Canada's health department said on Sunday the 1.5 million doses of the Astrazeneca Plc (AZN.L) Covid-19 vaccine imported from Emergent BioSolutions' (EBS.N) Baltimore facility were safe and met quality specifications.
The US Food and Drug Administration (FDA) had stopped AstraZeneca from using the facility earlier this month and halted production of Johnson & Johnson's (JNJ.N) vaccine at the plant as it began investigations into an error that led to millions of doses of J&J's vaccine being ruined last month. read more
However, Health Canada said it reviewed test results of all vaccine lots that came into the country and found them to be safe.
J&J doses produced at the Baltimore, Maryland, site have not entered the country, the regulator said, adding that vaccines from the company anticipated to be imported next week were not made at that facility.
LEAVE A COMMENT Your email address will not be published. Required fields are marked*
Canada bids adieu to family killed in hate crime
Interfaith march honors Muslim family killed in Canada truck attack
Partial eclipse sweeps over northern hemisphere
Man accused of mowing down Canadian Muslim family to appear in court
Trudeau slams 'terrorist' killing of Muslim family
Killing of Muslim family a ‘terrorist attack’: Trudeau
Canada to move against far-right groups after Muslim family attack
Family of four killed in 'premeditated' Canada truck attack
Canada extends flight ban from India, Pak